In the context of economics and development, tobacco poses an especially thorny problem. There is no doubt that global tobacco businesses are responsible for making and promoting a product with extremely damaging long-term effects on health and that these effects have been downplayed disingenuously for decades. It is encouraging to see the WHO campaign noting that "an increasing number of countries are creating firewalls to ward off interference from the tobacco industry in government tobacco control policy." However, the perverse discipline of tobacconomics invites skepticism. China, for example, has more than 300 million smokers, with the health of many more people likely to be damaged by the effects of secondhand smoke. The near-monopoly of China's state tobacco manufacturer has been estimated to contribute about 7% of government revenues [4] , which has surely contributed to the country's development and economic growth. Despite the promise of taxation and other population-level approaches for reduction of the health burden of tobacco use [5] , the damaging symbiotic relationship between tobacco use and economic growth could constrain implementation of smoking cessation strategies in the countries in which they are most needed.
WHO's next Director-General, whose identity was unknown at the time of writing, is expected to be appointed at the World Health Assembly in May of this year. The successful candidate will have a demanding to-do list [6] , but one of his or her highest priorities should be to bypass the complexity of the SDGs and take decisive action against the world's pandemic of tobacco use. WHO has a noteworthy track record on the issue, with the 2005 Framework Convention on Tobacco Control having led the international public health agenda towards action on tobacco, including the imposition of taxes and other measures to reduce demand, bans on advertising, and the provision of smoking cessation programs (observation of the treaty is included as SDG target 3.A, for "strengthened implementation. . .as appropriate"). However, the grim facts on smoking incidence and prevalence, and on the grave and growing health consequences, call strongly for renewed action against tobacco. As sponsor of the "Ebola ça suffit!" ring-vaccination trial [7] , WHO has recently shown its ability to take the lead in developing scientific solutions to important health threats. Because conflicts of interest in the funding and process of scientific studies are so common in the domain of tobacco and smoking, active involvement by WHO could have special value in this area. In addition to taking urgent steps to reenergize the public health trajectory in low-and middle-income countries to improve tobacco control, providing new scientific leadership on the issue-whether towards novel behavioral approaches, smoking cessation interventions, or harm reduction-should also be a priority for the agency.
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